Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Experts Perspective

Experts Perspective

Learn more
The Stigma of Rare Diseases

The Stigma of Rare Diseases

Learn more
Prurigo Nodularis is a distinct, Chronic, Neural and Immune- Mediated skin disease characterized by intense itch and Nodular Lesions¹

Prurigo Nodularis is a distinct, Chronic, Neural and Immune- Mediated skin disease characterized by intense itch and Nodular Lesions¹

Learn more
The role and importance of Patients Associations and Scientific societies ; Oman Experience

The role and importance of Patients Associations and Scientific societies ; Oman Experience

Learn more
Multidisciplinary approaches in Rare Disease Patient management

Multidisciplinary approaches in Rare Disease Patient management

Learn more
Type 2 Inflammation may play a role in Prurigo Nodularis Pathophysiology1

Type 2 Inflammation may play a role in Prurigo Nodularis Pathophysiology1

Exact pathophysiology of PN is currently not understood. Based on the evolving literature, type 2 inflammation may play a role in PN.

Learn more
De-escalation to Clopidogrel in AMI

De-escalation to Clopidogrel in AMI

Learn more
How is LSDs prevalence & epidemiology different in our region?

How is LSDs prevalence & epidemiology different in our region?

Learn more
Global use of RAM and Thromboprophylaxis in hospitalized patients

Global use of RAM and Thromboprophylaxis in hospitalized patients

Learn more
Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab

Achievement of ESC/EAS LDL-C Treatment Goals After an ACS with Statin and Alirocumab

Learn more
Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

Learn more
Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

Learn more